Ondine Other Current Liab vs Short Term Debt Analysis

OBI Stock

8.00 0.13 1.60%

Ondine Biomedical financial indicator trend analysis is much more than just breaking down Ondine Biomedical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ondine Biomedical is a good investment. Please check the relationship between Ondine Biomedical Other Current Liab and its Short Term Debt accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Other Current Liab vs Short Term Debt

Other Current Liab vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ondine Biomedical Other Current Liab account and Short Term Debt. At this time, the significance of the direction appears to have very week relationship.

The correlation between Ondine Biomedical's Other Current Liab and Short Term Debt is 0.23. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Ondine Biomedical, assuming nothing else is changed. The correlation between historical values of Ondine Biomedical's Other Current Liab and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of Ondine Biomedical are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Other Current Liab i.e., Ondine Biomedical's Other Current Liab and Short Term Debt go up and down completely randomly.

Correlation Coefficient

0.23

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Other Current Liab

Short Term Debt

Most indicators from Ondine Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ondine Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

The current year's Issuance Of Capital Stock is expected to grow to about 9.1 M, whereas Selling General Administrative is forecasted to decline to about 7.8 M.

	2021	2022	2023	2024 (projected)
Interest Expense	1.2M	30K	38K	36.1K
Depreciation And Amortization	514K	493K	587K	517.3K

Interest Expense Depreciation And Amortization

Ondine Biomedical fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Current Liab	Other Current Assets	Short Term Debt	Inventory	Intangible Assets	Short Term Investments	Capital Surpluse	Common Stock
Total Assets		-0.39	0.79	0.32	-0.82	-0.51	0.53	1.0	-0.45	-0.21	1.0	0.24	-0.29	-0.08	0.44	-0.38	1.0	-0.45	0.33	0.9	-0.46	0.67	-0.34	-0.2	0.17	0.7
Total Current Liabilities	-0.39		-0.87	-0.09	0.85	0.07	-0.47	-0.38	0.1	-0.33	-0.39	0.28	0.51	0.29	0.05	1.0	-0.39	0.99	0.34	-0.24	0.99	-0.4	0.17	-0.36	0.36	-0.3
Total Stockholder Equity	0.79	-0.87		0.21	-0.99	-0.29	0.59	0.78	-0.29	0.11	0.79	-0.08	-0.48	-0.23	0.17	-0.86	0.78	-0.89	-0.06	0.62	-0.89	0.63	-0.27	0.13	-0.13	0.57
Property Plant And Equipment Net	0.32	-0.09	0.21		-0.29	-0.66	0.12	0.36	-0.74	-0.04	0.37	0.45	-0.06	-0.12	0.79	-0.07	0.38	-0.16	0.62	0.33	-0.17	0.55	-0.8	-0.07	0.07	0.66
Net Debt	-0.82	0.85	-0.99	-0.29		0.35	-0.6	-0.81	0.38	-0.11	-0.82	-0.02	0.5	0.23	-0.26	0.83	-0.82	0.88	-0.04	-0.67	0.88	-0.65	0.36	-0.13	0.13	-0.62
Retained Earnings	-0.51	0.07	-0.29	-0.66	0.35		-0.66	-0.49	0.51	0.66	-0.5	-0.56	-0.28	0.02	-0.9	0.05	-0.54	0.16	-0.6	-0.67	0.17	-0.79	0.42	0.63	-0.57	-0.85
Accounts Payable	0.53	-0.47	0.59	0.12	-0.6	-0.66		0.5	-0.28	-0.42	0.51	0.24	0.01	-0.11	0.44	-0.47	0.53	-0.53	0.07	0.68	-0.53	0.64	-0.13	-0.43	0.41	0.69
Cash	1.0	-0.38	0.78	0.36	-0.81	-0.49	0.5		-0.52	-0.15	1.0	0.27	-0.33	-0.08	0.46	-0.36	1.0	-0.43	0.36	0.89	-0.44	0.65	-0.4	-0.15	0.13	0.7
Non Current Assets Total	-0.45	0.1	-0.29	-0.74	0.38	0.51	-0.28	-0.52		-0.21	-0.52	-0.73	0.49	0.02	-0.79	0.08	-0.53	0.18	-0.6	-0.61	0.19	-0.26	0.96	-0.2	0.2	-0.51
Non Currrent Assets Other	-0.21	-0.33	0.11	-0.04	-0.11	0.66	-0.42	-0.15	-0.21		-0.15	-0.2	-0.78	-0.07	-0.38	-0.34	-0.18	-0.28	-0.34	-0.33	-0.28	-0.53	-0.35	0.98	-0.91	-0.47
Cash And Short Term Investments	1.0	-0.39	0.79	0.37	-0.82	-0.5	0.51	1.0	-0.52	-0.15		0.28	-0.34	-0.08	0.47	-0.37	1.0	-0.44	0.36	0.9	-0.45	0.65	-0.41	-0.14	0.12	0.7
Net Receivables	0.24	0.28	-0.08	0.45	-0.02	-0.56	0.24	0.27	-0.73	-0.2	0.28		-0.06	-0.11	0.77	0.3	0.3	0.18	0.83	0.56	0.17	0.16	-0.62	-0.18	0.13	0.36
Common Stock Shares Outstanding	-0.29	0.51	-0.48	-0.06	0.5	-0.28	0.01	-0.33	0.49	-0.78	-0.34	-0.06		0.12	0.0	0.51	-0.33	0.5	0.23	-0.27	0.5	0.27	0.56	-0.84	0.86	0.18
Non Current Liabilities Total	-0.08	0.29	-0.23	-0.12	0.23	0.02	-0.11	-0.08	0.02	-0.07	-0.08	-0.11	0.12		-0.01	0.28	-0.08	0.29	0.0	-0.08	0.29	-0.1	0.07	-0.08	0.08	-0.07
Other Stockholder Equity	0.44	0.05	0.17	0.79	-0.26	-0.9	0.44	0.46	-0.79	-0.38	0.47	0.77	0.0	-0.01		0.07	0.5	-0.05	0.72	0.67	-0.06	0.54	-0.73	-0.34	0.27	0.7
Total Liab	-0.38	1.0	-0.86	-0.07	0.83	0.05	-0.47	-0.36	0.08	-0.34	-0.37	0.3	0.51	0.28	0.07		-0.37	0.99	0.36	-0.23	0.99	-0.39	0.15	-0.36	0.36	-0.28
Total Current Assets	1.0	-0.39	0.78	0.38	-0.82	-0.54	0.53	1.0	-0.53	-0.18	1.0	0.3	-0.33	-0.08	0.5	-0.37		-0.45	0.37	0.91	-0.45	0.67	-0.42	-0.17	0.14	0.72
Short Long Term Debt Total	-0.45	0.99	-0.89	-0.16	0.88	0.16	-0.53	-0.43	0.18	-0.28	-0.44	0.18	0.5	0.29	-0.05	0.99	-0.45		0.24	-0.33	1.0	-0.47	0.23	-0.31	0.32	-0.38
Other Current Liab	0.33	0.34	-0.06	0.62	-0.04	-0.6	0.07	0.36	-0.6	-0.34	0.36	0.83	0.23	0.0	0.72	0.36	0.37	0.24		0.46	0.23	0.44	-0.51	-0.37	0.37	0.55
Other Current Assets	0.9	-0.24	0.62	0.33	-0.67	-0.67	0.68	0.89	-0.61	-0.33	0.9	0.56	-0.27	-0.08	0.67	-0.23	0.91	-0.33	0.46		-0.33	0.58	-0.45	-0.28	0.21	0.69
Short Term Debt	-0.46	0.99	-0.89	-0.17	0.88	0.17	-0.53	-0.44	0.19	-0.28	-0.45	0.17	0.5	0.29	-0.06	0.99	-0.45	1.0	0.23	-0.33		-0.48	0.24	-0.31	0.31	-0.39
Inventory	0.67	-0.4	0.63	0.55	-0.65	-0.79	0.64	0.65	-0.26	-0.53	0.65	0.16	0.27	-0.1	0.54	-0.39	0.67	-0.47	0.44	0.58	-0.48		-0.19	-0.57	0.57	0.95
Intangible Assets	-0.34	0.17	-0.27	-0.8	0.36	0.42	-0.13	-0.4	0.96	-0.35	-0.41	-0.62	0.56	0.07	-0.73	0.15	-0.42	0.23	-0.51	-0.45	0.24	-0.19		-0.35	0.36	-0.4
Short Term Investments	-0.2	-0.36	0.13	-0.07	-0.13	0.63	-0.43	-0.15	-0.2	0.98	-0.14	-0.18	-0.84	-0.08	-0.34	-0.36	-0.17	-0.31	-0.37	-0.28	-0.31	-0.57	-0.35		-0.98	-0.53
Capital Surpluse	0.17	0.36	-0.13	0.07	0.13	-0.57	0.41	0.13	0.2	-0.91	0.12	0.13	0.86	0.08	0.27	0.36	0.14	0.32	0.37	0.21	0.31	0.57	0.36	-0.98		0.55
Common Stock	0.7	-0.3	0.57	0.66	-0.62	-0.85	0.69	0.7	-0.51	-0.47	0.7	0.36	0.18	-0.07	0.7	-0.28	0.72	-0.38	0.55	0.69	-0.39	0.95	-0.4	-0.53	0.55

Click cells to compare fundamentals

Ondine Biomedical Account Relationship Matchups

Ondine Biomedical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.9M	2.6M	34.1M	16.6M	5.7M	9.0M
Total Current Liabilities	28.7M	35.8M	3.9M	3.9M	3.5M	3.3M
Total Stockholder Equity	(26.1M)	(33.8M)	29.7M	11.6M	2.1M	2.2M
Property Plant And Equipment Net	849K	671K	601K	1.4M	949K	663.6K
Net Debt	27.7M	30.8M	(29.6M)	(12.2M)	(2.4M)	(2.3M)
Retained Earnings	(165.9M)	(182.1M)	(232.5M)	(251.9M)	(266.3M)	(253.0M)
Accounts Payable	183K	237K	1.2M	388K	1.4M	923.0K
Cash	306K	626K	30.4M	13.1M	3.0M	4.5M
Non Current Assets Total	1.9M	888K	636K	1.4M	984K	1.3M
Non Currrent Assets Other	42K	40K	46K	35K	36K	33.3K
Cash And Short Term Investments	306K	626K	30.4M	13.1M	3.0M	5.6M
Net Receivables	24K	543K	248K	133K	220K	269.6K
Liabilities And Stockholders Equity	2.9M	2.6M	34.1M	16.6M	5.7M	9.0M
Non Current Liabilities Total	316K	678K	561K	1.0M	159K	151.1K
Other Stockholder Equity	20.3M	28.8M	27.2M	28.5M	28.8M	33.0M
Total Liab	29.0M	36.5M	4.5M	4.9M	3.6M	3.5M
Total Current Assets	1.0M	1.7M	33.5M	15.1M	4.8M	7.7M
Short Long Term Debt Total	28.0M	31.5M	739K	896K	541K	514.0K
Other Current Liab	760K	4.2M	2.1M	3.2M	1.7M	1.0M
Other Current Assets	236K	717K	2.1M	710K	703K	1.1M
Short Term Debt	27.7M	31.4M	645K	359K	382K	362.9K
Inventory	468K	404K	1.1M	1.3M	1.1M	646.2K
Capital Lease Obligations	569K	310K	242K	896K	541K	469.7K
Net Invested Capital	1.4M	334K	30.2M	11.6M	2.1M	2.0M
Net Working Capital	(27.7M)	(34.0M)	29.6M	11.2M	1.3M	1.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Other Information on Investing in Ondine Stock

Balance Sheet is a snapshot of the financial position of Ondine Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Ondine Biomedical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ondine Biomedical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ondine currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ondine Other Current Liab vs Short Term Debt Analysis

Other Current Liab vs Short Term Debt

Other Current Liab vs Short Term Debt Correlation Analysis

Correlation Coefficient

Other Current Liab

Short Term Debt

Ondine Biomedical fundamental ratios Correlations

Ondine Biomedical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ondine Biomedical fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Ondine Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash

Net Debt	- 0.99	Total Stockholder Equity
Capital Surpluse	- 0.98	Short Term Investments
Capital Surpluse	- 0.91	Non Currrent Assets Other
Other Stockholder Equity	- 0.9	Retained Earnings
Short Term Debt	- 0.89	Total Stockholder Equity
Short Long Term Debt Total	- 0.89	Total Stockholder Equity